(Q46896203)

26 December 2017

title

Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen (English)

1 reference

26 December 2017

author name string

Frère P

1

1 reference

26 December 2017

Baron F

2

1 reference

26 December 2017

Bonnet C

3

1 reference

26 December 2017

Hafraoui K

4

1 reference

26 December 2017

Pereira M

5

1 reference

26 December 2017

Willems E

6

1 reference

26 December 2017

Fillet G

7

1 reference

26 December 2017

Beguin Y

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

26 December 2017

Bone Marrow Transplantation

published in

1 reference

26 December 2017

volume

37

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

411-418

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705255

exact match

0 references

cites work

Allogeneic hematopoietic stem cell transplantation--yesterday, today, and tomorrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Nonmyeloablative allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Mixed chimerism: preclinical studies and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

7 January 2021

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

7 January 2021

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

7 January 2021

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

7 January 2021

Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

7 January 2021

Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

7 January 2021

CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

7 January 2021

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705255

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705255

1 reference

26 December 2017

PubMed ID

16415900

1 reference

26 December 2017